Social network embraces clinical trial | Research roundup

April 25, 2011 by MassDevice staff

PatientsLikeMe touts the results of a patient-initiated ALS-treatment study that indicates the benefits of social networking in clinical trials.

Clinical trials roundup

Social networking may someday become a part of clincal trials on medical devices and drugs.

A recent trial found that lithium carbonate didn't slow the progression of Lou Gehrig's disease, or amyotrophic lateral sclerosis (ALS), but the study also indicated that the use of a social network to enroll patients and report and collect data could facilitate future studies.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.